News

This clinical study determines the safety and tolerability of AP24534, as well as its pharmacokinetics and its pharmacodynamics. Since all participants in the trial will have well-characterized malignancies,

In the letter, the FDA requested information similar to that outlined in its approvable letter for bazedoxifene’s new drug application for the prevention of postmenopausal osteoporosis issued in

Rifampin for Injection is a semi synthetic antibiotic indicated for the treatment of both tuberculosis and meningococcal carriers. Akorn-Strides is a joint venture that was formed in 2005

The randomized, double-blind, placebo controlled, parallel group study established clinical proof-of-concept and demonstrated a statistically significant improvement over placebo in the endpoint of overall subject global assessment of

The Covidien Single-Incision Laparoscopic Surgery (SILS) Procedure Kit is scheduled for commercialization in the summer of 2008, and customized kit solutions are also forthcoming to enable SILS procedures

Dr Andreas Pfuetzner, Biodel’s current chief medical officer (CMO) will remain on Biodel’s management team as the company’s CMO in Europe and as a member of the company’s

The BacJac system is designed to relieve pain in patients with neurogenic intermittent claudication due to lumbar spinal stenosis. The BacJac achieves spinal decompression by limiting the symptomatic

The Stature VBR is a radiolucent MIS compatible spacer system designed to utilize a self-distracting technique in the treatment of various pathologies of the thoracic and lumbar spine.

His responsibilities include overseeing and managing all aspects of the PEGylation Business Unit, including research and manufacturing, as well as operations across the company. He will also serve